Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Pharmaceutical industry ethics

This article presents a brief sketch of the economics of the R D intensive ethical pharmaceutical industry, highlighting its dynamic characteristics. The approach taken here minimizes the use of static analysis, and thus avoids the use of pure or perfect competition as an analytical tool. In this theoretical discussion, certain empirical studies will be cited as support for aspects of the theory being developed. [Pg.1450]

Cocks, D.L. Product innovation and the dynamic elements of competition in the ethical pharmaceutical industry. In Drug Development and Marketing, Helms, R.B., Ed. American Enterprise Institute Washington, D.C., 1975 225-254. [Pg.1453]

Analysis of financial returns in the researchintensive ethical pharmaceutical industry as a whole and... [Pg.265]

However, in the 21st century, the ethical pharmaceutical industry has been fully geared towards the production of relatively safer, less toxic, more effective, higher therapeutic index, novel, innovative medicaments that will evidently help the mankind to afford a disease-free society besides, the elder ones with a glaring hope to live a still longer life span. [Pg.12]

Following is the brief description in a chromological order for the development of ethical pharmaceutical industry in the world ... [Pg.12]

Three major findings are advanced (1) "External sources—sources other than the innovating firm— have played a major role in the technological progress of the ethical pharmaceutical industry in the D.S. These external sources provided 54% of the discoveries which produced pharmaceutical innovations during 1935-1962. in particular the in-... [Pg.129]

Sapienza AM. R D collaboration as a global competitive tactic-biotechnology and the ethical pharmaceutical industry. R D Manage 1989 19(4) 285-9. [Pg.230]

In short, we return to C. P. Snow s recommendation that the scientist and humanist converse more. The conversations, analysis, and discussion should include the third culture, the technologist. Therefore, although we have not provided specihc and detailed analysis of issues related to computer use in the pharmaceutical industry, believing as we do that that sort of analysis is for the specialized philosopher doing conceptual analysis in computers ethics, we do urge that applied philosophers be part of the research team. Also, in the dynamic and flexible world of technology, applied philosophers—not just the people in the held of computers—should help draft policy statements and codes of conduct. [Pg.724]

Gewertz NM, Amado R. intellectual property and the pharmaceutical industry a moral crossroads between health and property. J Business Ethics 2004 55 295-308. [Pg.728]

In in vivo studies, an important issue is the quality of ECG recordings and the methods used for the analysis. A few years ago, a survey reported on the practice in the pharmaceutical industry to assess the potential for QT prolongation and concluded that the majority view in the industry is not necessarily best practice [153]. After this publication, a lot of work has been done to improve the performance of in vivo models, although it should be acknowledged that their cost (together with some ethical considerations on the rational use of animals) makes them unsuitable for large-scale screening. [Pg.71]

From this and other guidelines have developed current principles of good clinical practice ( GCP ) centred on ethical review by committee, with a favourable opinion being at least a moral precondition of the commencement of any human research project. In 1989, the CPMP (the Committee for Proprietary Medicinal Products) adopted GCP guidelines (based on a previous 1987 version) for the European Union. Although they were not in themselves legally enforceable, the pharmaceutical industry saw compliance with the guidelines... [Pg.392]

The aim of the Code of Practice for the Pharmaceutical Industry is to ensure that the promotion of medicines to members of the health professions and to administrative staff is carried out in a responsible, ethical and professional manner. The Code recognises and seeks to achieve a balance between the needs of patients, industry, health professionals and the general public, bearing in mind the political and social environment within which the industry operates and the statutory controls governing medicines. [Pg.730]


See other pages where Pharmaceutical industry ethics is mentioned: [Pg.176]    [Pg.178]    [Pg.180]    [Pg.182]    [Pg.184]    [Pg.382]    [Pg.1453]    [Pg.68]    [Pg.11]    [Pg.13]    [Pg.176]    [Pg.178]    [Pg.180]    [Pg.182]    [Pg.184]    [Pg.382]    [Pg.1453]    [Pg.68]    [Pg.11]    [Pg.13]    [Pg.223]    [Pg.726]    [Pg.77]    [Pg.101]    [Pg.14]    [Pg.37]    [Pg.129]    [Pg.360]    [Pg.386]    [Pg.364]    [Pg.375]    [Pg.402]    [Pg.420]    [Pg.64]    [Pg.108]    [Pg.73]    [Pg.76]    [Pg.737]    [Pg.17]    [Pg.275]    [Pg.371]    [Pg.6]    [Pg.167]    [Pg.169]   


SEARCH



Pharmaceutical industry

Pharmaceutical industry ethical issues

© 2024 chempedia.info